Inability of NCoR/SMRT to repress androgen receptor transcriptional activity in prostate cancer cell lines
Related Experiment Video
Updated: May 31, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Martin Laschak1, Marina Bechtel, Klaus-Dieter Spindler
1Institute of General Zoology and Endocrinology, Ulm University, Albert-Einstein-Allee 11, D-89069 Ulm, Germany. martin.laschak@uni-ulm.de
Abstract:
The molecular mechanisms leading to castration-resistant prostate cancer (CRPC) are poorly understood. Among several mechanisms leading to CRPC growth a dysregulation of androgen receptor (AR) co-regulators (i.e. up-regulation of co-activators or down-regulation of co-repressors) is discussed. There are numerous reports demonstrating an increased expression of co-activators during prostate cancer progression. On the contrary, the impact of co-repressors on tumor growth and development is less clear. In this study we compared the effects of two known co-repressors, NCoR and SMRT, on AR transcriptional activity in prostate cancer (PCa) cell lines and compared them to that in COS-1 cells. Interestingly, we found that NCoR/SMRT overexpression did not repress AR-dependent gene expression in the PCa cell lines, but rather activated it. This finding is probably due to an impaired AR-co-repressor interaction in the prostate cancer cell lines. In conclusion, we provide evidence that up-regulation of NCoR or SMRT may increase transcriptional activity of the AR in a cell type-specific context.
Insights
Overexpression of NCoR or SMRT co-repressors unexpectedly activated androgen receptor (AR) activity in prostate cancer cells, unlike in other cell types. This suggests a cell-specific interaction impacting castration-resistant prostate cancer (CRPC) growth.
Area of Science:
- Molecular biology
- Oncology
- Cellular signaling
Background:
- Castration-resistant prostate cancer (CRPC) mechanisms remain unclear.
- Androgen receptor (AR) co-regulator dysregulation is implicated in CRPC.
- The role of co-repressors in prostate cancer progression is less understood than co-activators.
Purpose of the Study:
- To investigate the impact of NCoR and SMRT co-repressors on AR transcriptional activity.
- To compare the effects in prostate cancer (PCa) cell lines versus COS-1 cells.
Main Methods:
- Comparative analysis of NCoR/SMRT effects on AR activity.
- Utilized prostate cancer cell lines and COS-1 cells for experimentation.
Main Results:
- NCoR/SMRT overexpression did not repress AR-dependent gene expression in PCa cell lines.
- NCoR/SMRT unexpectedly activated AR-dependent gene expression in PCa cell lines.
- Evidence suggests impaired AR-co-repressor interaction in PCa cells.
Conclusions:
- Up-regulation of NCoR or SMRT can enhance AR transcriptional activity.
- This effect is context-dependent, varying by cell type.
- Findings provide insights into CRPC molecular mechanisms.
Related Concept Videos
Abnormal Proliferation
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Non-LTR Retrotransposons
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

